Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Upgraded to Hold at The Goldman Sachs Group

Key Points

• Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was upgraded to a "hold" rating by The Goldman Sachs Group, and the stock opened down about 3.4% at $10.94 following the report.
• The company posted a quarterly beat with $0.28 EPS vs. $0.19 expected and revenue of $966.5M versus $848.4M, and analysts now forecast 0.66 EPS for the current fiscal year.
• Shionogi has a market cap of about $18.6B, strong liquidity and minimal leverage (current ratio 5.84, quick ratio 5.21, debt-to-equity 0.01), and valuation metrics of a P/E 14.39 and P/E/G 0.87.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was upgraded by investment analysts at The Goldman Sachs Group to a "hold" rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 3.4%

Shares of Shionogi & Co., Ltd. Unsponsored ADR stock opened at $10.94 on Wednesday. Shionogi & Co., Ltd. Unsponsored ADR has a 52-week low of $7.27 and a 52-week high of $12.00. The company has a 50 day moving average of $11.05 and a 200 day moving average of $9.52. The company has a quick ratio of 5.21, a current ratio of 5.84 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $18.61 billion, a P/E ratio of 14.39, a P/E/G ratio of 0.87 and a beta of 0.19.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.09. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. The company had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. As a group, research analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.